CURX vs PARA · $8.9M cap vs rev $5.0M
Curanex Pharmaceuticals Inc Common Stock (CURX) versus PARA (PARA) — a side-by-side from cached financials, not a winner call.
Curanex Pharmaceuticals Inc Common Stock (CURX) is a biotechnology company listed on NASDAQ.
PARA (PARA) common stock.
CURX does not have a complete income-statement cache yet.
Latest reported PARA revenue for 2026-06-30 was $5.0M. Net income was -$13.4M. Revenue was up 84.3% from 2026-03-31 to 2026-06-30. PARA currently screens at market cap $0.
CURX currently screens at market cap $8.9M. PARA currently screens at market cap $0.
Not investment advice. Open the CURX and PARA stock pages for the full models.
Not investment advice.